Faculty of Pharmacy, The University of Sydney, NSW, Australia.
Res Social Adm Pharm. 2012 Nov-Dec;8(6):487-98. doi: 10.1016/j.sapharm.2012.01.002. Epub 2012 Mar 3.
Previous research has demonstrated that some patients who are at risk of experiencing medication-related problems express a lack of willingness to use pharmacist-provided medication management services. Little is known about the factors that influence willingness to use these services among patients who have not yet experienced the service.
The aim of this study was to test a model of willingness to use the Australian Home Medicines Review (HMR) service. Specifically, this study aimed to determine the influence of positive and negative outcome expectancies and communication efficacy over willingness among patients who were eligible to receive the service but have not yet experienced it.
A cross-sectional survey was conducted with patients who were recruited by 264 community pharmacists throughout Australia. Patients were included in the study if they had not yet experienced HMR but were taking more than 5 medicines daily or more than 12 doses daily. Measurement scales were developed using exploratory and confirmatory factor analyses. Structural equation modeling was used to test the model.
Questionnaires received from 286 patients (15.6%) were analyzed. Multi-item measurement scales were observed to have acceptable construct reliabilities (range, 0.69-0.94). Importantly, respondents held overall neutral expectations about the personal benefits of HMR (positive outcome expectancies) but high communication efficacy. Structural equation modeling revealed that positive outcome expectancies (β=0.56, P<.001) and communication efficacy (β=0.25, P<.05) influenced willingness to use, whereas negative outcome expectancies had no significant effect.
The extent to which patients believe that HMR would provide them with increased medicines knowledge, improve their medicines management capability, and reduce their medicine concerns had a significant influence over willingness to use the service. Because these expectancies are relatively low, there appears to be significant scope for increasing patient demand for these services. Patient-directed material about medication management services should highlight the provision of medication information.
先前的研究表明,一些有发生药物相关问题风险的患者表示不愿意使用药剂师提供的药物管理服务。对于尚未体验过该服务的患者,影响其使用意愿的因素知之甚少。
本研究旨在检验澳大利亚家庭用药审查(HMR)服务使用意愿模型。具体而言,本研究旨在确定积极和消极的预期结果以及沟通效能对尚未体验过该服务的患者使用意愿的影响。
本研究通过澳大利亚 264 家社区药剂师招募患者进行横断面调查。如果患者每日服用超过 5 种药物或每日服用超过 12 剂,但尚未接受 HMR,则纳入研究。使用探索性和验证性因子分析开发测量量表。使用结构方程模型检验模型。
对 286 名患者(15.6%)的问卷进行了分析。观察到多项目测量量表具有可接受的结构可靠性(范围为 0.69-0.94)。重要的是,受访者对 HMR 的个人收益(积极预期结果)持总体中立态度,但对沟通效能持高度肯定态度。结构方程模型显示,积极的预期结果(β=0.56,P<.001)和沟通效能(β=0.25,P<.05)影响使用意愿,而消极的预期结果则没有显著影响。
患者认为 HMR 将为他们提供更多的药物知识、提高药物管理能力并减少药物相关担忧的程度,对其使用服务的意愿有重大影响。由于这些预期相对较低,似乎有很大的空间可以增加患者对这些服务的需求。关于药物管理服务的面向患者的材料应强调提供药物信息。